The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis

NCT05770271 | Completed DMC

• 1 other identifier: jia19960129
• Study Type: interventional
• Target: 21
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to test whether spraying the itching of inflammation skin and groin patients by use of the novel electrolyzed water spray will produce improvement in the condition of itching.

Conditions

Groin Infection; Neurodermatitis; Psoriasis; Eczema

Keywords

Electrolyzed water device; Hydroxyl radical; Tap water; Spray; Itching

Outcome Measures

Primary Outcomes (1)

• An itching scale made by modifying the Numeric Pain Rating Scale (NPRS)

  This Score is based on descriptions of the itching that patients rate 0-10 to assess the condition of their itching. A higher score means a worse outcome. 0 means "no itching " and 10 means "the most itching".

  1 hour

Secondary Outcomes (1)

• A skin signs scale made by modifying the Numeric Pain Rating Scale (NPRS).

  10 days

Study Arms (1)

The mild senile groin eczema, neurodermatitis and psoriasis and one treatment

EXPERIMENTAL

Participants with itching of mild senile groin eczema, neurodermatitis and psoriasis will receive one treatment with the device and complete the questionnaire.

Device: The novel electrolyzed water spray

Interventions

The novel electrolyzed water spray DEVICE

Study staff will use the novel electrolyzed water spray device and spray for approximately 5 minutes on the participant's diseased area until half a bottle (200ml) of water is used. The patients use electrolyzed water to treat the diseased area, two times a day, for 10 days. The trial consists of 10 study visits (day 1-day 10). The relief of mild senile groin eczema, neurodermatitis and psoriasis evaluation and adverse event assessments will be performed at each visit. Safety analysis will be assessed based on the reports of adverse events during the study.

The mild senile groin eczema, neurodermatitis and psoriasis and one treatment

Eligibility Criteria

• Age: 35 Years - 55 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• mild senile groin eczema, neurodermatitis and psoriasis.

You may not qualify if:

• severe senile groin eczema, neurodermatitis and psoriasis.
• people with cognitive disorders.
• years or older.

Sponsors & Collaborators

• Dove Medical Press Ltd: lead

Study Sites (1)

Huinuode Biotechnology Co., Ltd.

Qingdao, China

Location

MeSH Terms

Conditions

Neurodermatitis; Psoriasis; Eczema; Pruritus

Condition Hierarchy (Ancestors)

Dermatitis; Skin Diseases; Skin and Connective Tissue Diseases; Skin Diseases, Eczematous; Skin Diseases, Papulosquamous; Skin Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Masking Details: An open label, single arm and before and after treatment comparison study
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: NETWORK
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 26, 2023
• First Posted: March 15, 2023
• Study Start: January 29, 2023
• Primary Completion: July 20, 2023
• Study Completion: January 20, 2024
• Last Updated: April 25, 2024

Record last verified: 2023-02

Data Sharing

• IPD Sharing: Will share
• Shared Documents: CSR
• Time Frame: until publication of this clinical study and international patent granted

Locations

CN (1)